Literature DB >> 2312040

Diagnostic and pathogenetic implications of urinary coproporphyrin excretion in the Dubin-Johnson syndrome.

M Frank1, M Doss, D G de Carvalho.   

Abstract

The Dubin-Johnson syndrome (DJS), a hereditary conjugated hyperbilirubinemia, is associated with an impairment of porphyrin metabolism. Total urinary coproporphyrin (CP) excretion and the urinary CP isomer I and III constellation were examined in 15 patients with DJS and 12 unaffected family members, and then compared with 50 unrelated control persons (55 +/- 15 nmol/24 h of total CP: 27 +/- 3% of isomer I; +/- SD). The patients with DJS excreted 80 +/- 7% (+/- SD) of CP isomer I (p less than 0.001). The isomer relation in two young children, 3 and 5 years old, shows an isomer reversal, with isomer I of about 95%. Studies done on four families from our patients with DJS indicate and confirm the autosomal recessive mode of inheritance. Total urinary CP was found to be elevated in subjects with DJS, reaching a mean value of 164 +/- 123 nmol/24 h (upper limit 120 nmol/24 h). Fecal CP isomers I and III were found to be in the usual physiological proportion to each other, but total fecal CP excretion had declined to the lower normal level (10 +/- nmol/g, n = 8). The pathogenetic mechanisms in DJS have not yet been fully worked out. Four possible explanations are currently under discussion: 1. an impaired hepatic excretory function: 2. a uroporphyrinogen III synthase defect; 3. an increase in porphobilinogen deaminase (uroporphyrinogen synthase) activity, or 4. a membrane-associated transport disorder with secondary metabolic changes of the isomer pool and enzyme activities.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2312040

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  9 in total

1.  Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome.

Authors:  S Toh; M Wada; T Uchiumi; A Inokuchi; Y Makino; Y Horie; Y Adachi; S Sakisaka; M Kuwano
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

2.  Urinary coproporphyrin I/(I + III) ratio as a surrogate for MRP2 or other transporter activities involved in methotrexate clearance.

Authors:  Isabelle Benz-de Bretagne; Noël Zahr; Amélie Le Gouge; Jean-Sébastien Hulot; Caroline Houillier; Khe Hoang-Xuan; Emmanuel Gyan; Séverine Lissandre; Sylvain Choquet; Chantal Le Guellec
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

3.  Postoperative management following massive hepatectomy in a patient with Dubin-Johnson syndrome: report of a case.

Authors:  S Ueno; G Tanabe; K Hanazono; H Ogawa; S Yoshidome; T Aikou; A Yoshida
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

4.  Mutation analysis of the ABCC2 gene in Chinese patients with Dubin-Johnson syndrome.

Authors:  Lina Wu; Wei Zhang; Siyu Jia; Xinyan Zhao; Donghu Zhou; Anjian Xu; Weijia Duan; Zhen Wu; Hai Li; Sujun Zheng; Yuemin Nan; Jidong Jia; Jian Huang; Xiaojuan Ou
Journal:  Exp Ther Med       Date:  2018-09-03       Impact factor: 2.447

5.  Urinary elimination of coproporphyrins is dependent on ABCC2 polymorphisms and represents a potential biomarker of MRP2 activity in humans.

Authors:  Isabelle Benz-de Bretagne; Renaud Respaud; Patrick Vourc'h; Jean-Michel Halimi; Agnès Caille; Jean-Sébastien Hulot; Christian R Andres; Chantal Le Guellec
Journal:  J Biomed Biotechnol       Date:  2011-03-14

6.  PBPK Modeling of Coproporphyrin I as an Endogenous Biomarker for Drug Interactions Involving Inhibition of Hepatic OATP1B1 and OATP1B3.

Authors:  Takashi Yoshikado; Kota Toshimoto; Kazuya Maeda; Hiroyuki Kusuhara; Emi Kimoto; A David Rodrigues; Koji Chiba; Yuichi Sugiyama
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-09-30

Review 7.  Benign inheritable disorders of bilirubin metabolism manifested by conjugated hyperbilirubinemia-A narrative review.

Authors:  Mariana B Morais; Mariana Verdelho Machado
Journal:  United European Gastroenterol J       Date:  2022-07-20       Impact factor: 6.866

8.  Endogenous Coproporphyrin I and III are Altered in Multidrug Resistance-Associated Protein 2-Deficient (TR-) Rats.

Authors:  Jacqueline Bezençon; Chitra Saran; Janine Hussner; James J Beaudoin; Yueping Zhang; Hong Shen; John K Fallon; Philip C Smith; Henriette E Meyer Zu Schwabedissen; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2020-10-13       Impact factor: 3.534

9.  Dubin-Johnson syndrome presenting after acute viral hepatitis.

Authors:  Farhad Lahmi; Mohammad Roshani; Katayoun Khosravi; Morteza Azizi; Seyed Reza Mohebbi; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2011
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.